Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Katzenellenbogen

Showing results (141-150 of 277) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry|January 23, 2003
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypesUsha Ghosh, Deshanie Ganessunker, Viswajanani J Sattigeri, et al.
Nuclear Medicine and Biology|September 9, 2018
Preliminary evaluation of a novel <sup>18</sup>F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancerDong Zhou, Jinbin Xu, Cedric Mpoy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2005
Positron tomographic assessment of androgen receptors in prostatic carcinomaFarrokh Dehdashti, Joel Picus, Jeff M Michalski, et al.
Nuclear Medicine and Biology|August 6, 2008
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studiesDong Zhou, Terry L Sharp, Nicole M Fettig, et al.
European Journal of Medicinal Chemistry|March 17, 2009
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor betaMichael Waibel, Meri De Angelis, Fabio Stossi, et al.
Endocrinology|October 17, 2022
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Breast Cancer Research and Treatment|July 9, 2024
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell deathSandeep Kumar, Yvonne Ziegler, Blake N Plotner, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and betaFilippo Minutolo, Michela Antonello, Simone Bertini, et al.
Journal of Medicinal Chemistry|November 13, 2004
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activityDennis R Compton, Shubin Sheng, Kathryn E Carlson, et al.
Molecular Endocrinology (Baltimore, Md.)|November 25, 2005
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen actionWilliam R Harrington, Sung Hoon Kim, Cory C Funk, et al.
Pageof 28

Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry|January 23, 2003
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypesUsha Ghosh, Deshanie Ganessunker, Viswajanani J Sattigeri, et al.
Nuclear Medicine and Biology|September 9, 2018
Preliminary evaluation of a novel <sup>18</sup>F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancerDong Zhou, Jinbin Xu, Cedric Mpoy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2005
Positron tomographic assessment of androgen receptors in prostatic carcinomaFarrokh Dehdashti, Joel Picus, Jeff M Michalski, et al.
Nuclear Medicine and Biology|August 6, 2008
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studiesDong Zhou, Terry L Sharp, Nicole M Fettig, et al.
European Journal of Medicinal Chemistry|March 17, 2009
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor betaMichael Waibel, Meri De Angelis, Fabio Stossi, et al.
Endocrinology|October 17, 2022
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast CancerParama Dey, Alexander Wang, Yvonne Ziegler, et al.
Breast Cancer Research and Treatment|July 9, 2024
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell deathSandeep Kumar, Yvonne Ziegler, Blake N Plotner, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and betaFilippo Minutolo, Michela Antonello, Simone Bertini, et al.
Journal of Medicinal Chemistry|November 13, 2004
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activityDennis R Compton, Shubin Sheng, Kathryn E Carlson, et al.
Molecular Endocrinology (Baltimore, Md.)|November 25, 2005
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen actionWilliam R Harrington, Sung Hoon Kim, Cory C Funk, et al.
Pageof 28